Zhejiang Huakang Pharmaceutical Co., Ltd. Class ASSE: 605077

Announcement on Cancellation of Some Proposals for the 2025 Annual General Meeting, Addition of Interim Proposals, and Supplementary Meeting Notice

· Issued by Zhejiang Huakang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Cancellation of Some Proposals for the 2025 Annual General Meeting, Addition of Interim Proposals, and Supplementary Meeting Notice

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis